Both in Pharmaceuticals
FibroBiologics vs Aprea Therapeutics
Over the past year FBLG returned −88.2% and APRE returned −65.4%; their daily moves had a correlation of -0.07.
FBLG −88.2% APRE −65.4%Growth of $1, one year, split-adjusted
| Metric | FBLG | APRE |
|---|---|---|
| Price | $0.9300 | $0.4846 |
| Market cap | $6.6M | $6.1M |
| Today | +0.20% | −1.82% |
| 1 month | −22.8% | −33.0% |
| 6 months | −36.3% | −40.8% |
| Year to date | −79.3% | −43.2% |
| 1 year | −88.0% | −66.6% |
| Revenue growth (YoY) | — | −100.0% |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | 1,176.8× |
| Net cash | $3.5M | $41.2M |
| Dividend yield | — | — |
| Volatility (60d) | 97.5% | 95.6% |
| Short % of float | 6.0% | 5.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).